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Objectives. The present study investigated whether myocyte
injury can be assessed sensitively by measurement of serum levels
of cardiac troponin T (cTnT) in patients with clinically suspected
myocarditis and whether cTnT levels may predict the results of
histologic and immunohistologic analysis of endomyocardial bi-
opsy specimens.
Background. Conventionally used laboratory variables often
fail to show myocyte injury in patients with clinically suspected
myocarditis, possibly because of a low extent of myocardial injury
in these patients. Sensitive variables for myocyte injury have not
yet been investigated.
Methods. Eighty patients with clinically suspected myocarditis
were screened for creatine kinase (CK) activity, MB isoform of CK
(CK-MB) activity and cTnT. Endomyocardial biopsy specimens
were examined histologically and immunohistologically.
Results. cTnT was elevated in 28 of 80 patients with clinically
suspected myocarditis, CK in 4 and CK-MB in 1. Histologic
analysis alone of the endomyocardial biopsy specimen revealed
evidence of myocarditis in only five patients, all with elevated
cTnT levels. Twenty-three of 28 patients with elevated cTnT levels
had histologically negative findings for myocarditis. Additional
immunohistologic analysis revealed evidence of myocarditis in 26
(93%) of 28 patients with elevated cTnT levels and in 23 (44%) of
52 patients with normal cTnT levels. Mean cTnT levels were
higher in patients with myocarditis proved histologically or im-
munohistologically, or both, than in patients without myocarditis
(0.59 6 1.68 vs. 0.04 6 0.05, p < 0.001).
Conclusions. Measurement of serum levels of cTnT provides
evidence of myocyte injury in patients with clinically suspected
myocarditis more sensitively than does conventional determina-
tion of cardiac enzyme levels. Myocardial cell damage may be
present even in the absence of histologic signs of myocarditis.
Additional immunohistologic analysis often shows lymphocytic
infiltrates in these patients. Elevated levels of cTnT are highly
predictive for myocarditis in this group.
(J Am Coll Cardiol 1997;30:1354–9)
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In patients with clinically suspected myocarditis, laboratory
variables conventionally used to detect myocardial cell dam-
age, such as creatine kinase (CK) and creatine kinase MB
isoform (CK-MB) levels, are often within the normal range,
partly because they are present in normal serum and a small
amount of myocardial necrosis does not lead to increases that
exceed the normal range. Therefore, the definitive diagnosis of
myocarditis has to be established by the demonstration of
myocytolysis and lymphocytic infiltrates in endomyocardial
biopsy specimens (1–4). For clinical and also economic reasons
it would be desirable to find a noninvasive screening variable to
determine in patients with clinically suspected myocarditis
whether myocardial cell damage is present and endomyocar-
dial biopsy should be performed. Recently, a new and very
sensitive assay has been developed to detect cardiac troponin T
(cTnT) in the serum (5). CTnT is unique to cardiac tissue (6,7).
Using monoclonal antibodies specific for the cardiac isoform
of troponin T, a highly specific one-step double-monoclonal
sandwich assay has been established that shows very low
cross-reactivity with skeletal troponin T (8). In healthy volun-
teers, levels of circulating cTnT are nearly always below the
detection limit of the assay (9). In patients with unstable
angina pectoris, measurement of cTnT has proved to be more
sensitive than measurement of CK levels for the diagnosis of
myocardial injury, and increased serum levels of cTnT can be
used as a prognostic factor in these patients (10). The present
study investigates whether measurement of serum levels of
cTnT can sensitively provide evidence of myocardial cell
damage in patients with clinically suspected myocarditis and
whether increased levels of cTnT correlate with histologic
and immunohistologic findings in endomyocardial biopsy
specimens.
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Methods
Patient selection. Eighty patients with clinically suspected
myocarditis were enrolled in the study (52 men, 28 women
[mean age 49 6 14 years, range 12 to 85]). The diagnosis of
myocarditis was suspected because of the patients’ history and
symptoms and the clinical investigation. The patients were
examined by using invasive and noninvasive techniques includ-
ing physical examination, routine laboratory tests, electrocar-
diography, exercise electrocardiography, echocardiography,
right and left heart catheterization, coronary angiography, left
ventriculography and right heart myocardial biopsy.
Analysis of endomyocardial biopsy specimens. Endomyo-
cardial biopsy specimens were taken transvenously through the
femoral approach from the right heart side of the intraventric-
ular septum. From each patient, several specimens (at least
five) were analyzed. Analysis was performed in blinded fashion
by persons unaware of patient data and history. The endomyo-
cardial specimens were examined histologically according to
the Dallas criteria (1) and, additionally, immunohistologic
methods were applied (4,11). The histologic sections were
analyzed by light microscopy for evidence of myocardial ne-
crosis, interstitial fibrosis and the presence of lymphocytic
infiltrates (1). As the histologic evaluation of myocardial
biopsy specimens is known to be difficult and affected by many
problems (2,3,12) including high interobserver variability (13)
and sampling error (14), the biopsy specimens were therefore
examined additionally with immunohistologic techniques using
various monoclonal antibodies. Antibodies directed against
surface antigens of human lymphocytes (CD3, CD4, CD8)
were used to detect and quantitate lymphocytic cells in myo-
cardial tissue (4,11,15–18). Cell numbers are expressed as the
mean value of $10 counted high power fields (magnification
3400), each equivalent to 0.28 mm3. Additionally, using
antibodies against the major histocompatibility complex
(MHC) antigens, the expression of MHC I and II antigens was
analyzed. With these techniques, the diagnostic accuracy in the
biopsy specimens could be increased (18) and the interob-
server variability minimized (4,11).
The biopsy specimens were classified as showing “acute
myocarditis” when histologic sections of the specimens re-
vealed lymphocytic infiltrates in the neighborhood of myocar-
dial necrosis (1). Borderline myocarditis was diagnosed when
lymphocytic infiltrates were present in histologic sections with-
out myocyte necrosis (1). When the immunohistologic exami-
nation revealed .2.0 lymphocytes/high power field (equivalent
to .7.0 cells/mm3) (19) and increased expression of MHC I
and II antigens, the biopsy specimen was considered to show a
generalized activated inflammatory process of the myocardium
and was therefore classified as showing lymphocytic myocardi-
tis. When neither the histologic nor the immunohistologic
analysis revealed myocytolysis or lymphocytic infiltrates, the
biopsy specimens were classified as showing no myocarditis.
Measurement of cTnT, CK and CK-MB. Blood samples
were drawn at admission into tubes with no preservatives and
centrifuged at 2,000 3 g for 15 min. Serum was stored at
270°C, thawed once and assayed in batches. All assays were
performed in blinded fashion by a staff member who was
unaware of patient data and history. CTnT was measured with
a one-step double-monoclonal sandwich immunoassay (Boehr-
inger Mannheim, Mannheim, Germany) using two different
monoclonal antibodies specific for cTnT that recognize differ-
ent epitopes. The lower detection limit of the assay is stated by
the manufacturer as 0.04 ng/ml, although some investigators
(20) have shown the limit to be 0.015 ng/ml. The reference
range for cTnT is 0 to 0.1 ng/ml as stated by the manufacturer;
therefore, in the present study, levels .0.1 ng/ml were consid-
ered elevated. CK and CK-MB activity levels were measured
by using routine laboratory assay (upper reference limit 80
U/liter for CK activity and 10 U/liter for CK-MB activity
(21,22).
Statistical analysis. All results were expressed as mean
value 6 SD, except when stated otherwise. CTnT values of the
groups with and without myocarditis were analyzed with the
Mann-Whitney U test. Nominal or ordinal values were com-
pared by Fisher exact test (two-tailed) or chi-square test.
Continuous variables were analyzed by unpaired t test. Corre-
lation between lymphocyte density and cTnT levels in patients
with myocarditis was calculated by using the Spearman rank
correlation. A p value , 0.05 was considered to indicate
statistical significance.
Results
Levels of cTnT in patients with clinically suspected myo-
carditis. The serum cTnT levels of 80 patients with clinically
suspected myocarditis are shown in Figure 1. Elevated levels of
cTnT could be detected in 28 (35%) of 80 serum samples;
cTnT levels were undetectable or ,0.1 ng/ml in 52 (65%)
serum samples.
Among patients with elevated cTnT levels (cTnT1 pa-
tients), myocarditis was diagnosed (histologically or immuno-
histologically, or both) in 26 patients (93%); in 2 patients (7%)
the endomyocardial biopsy specimen was negative for myocar-
ditis (Fig. 1). In patients with normal cTnT levels (cTnT2
patients), evidence (histologic or immunohistologic, or both)
for myocarditis in the biopsy specimen was found in 23 patients
(44%); in 29 patients (56%), the specimens showed no sign of
myocarditis. Mean cTnT levels were higher in patients with
histologically or immunohistologically proved myocarditis than
in patients without myocarditis (0.59 6 1.68 vs. 0.04 6 0.05,
Abbreviations and Acronyms
CK 5 creatine kinase
CK-MB 5 MB isoform of creatine kinase
cTnT 5 cardiac troponin T
cTnT1 patients 5 patients with elevated serum levels of cardiac
troponin T
cTnT2 patients 5 patients without elevated serum levels of cardiac
troponin T
MHC 5 major histocompatibility complex
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p , 0.001). The sensitivity of the cTnT assay for the detection
of myocarditis (histologically or immunohistologically, or both)
was 53%, the specificity 94%, the positive predictive value
93%, the negative predictive value 56% and the effectiveness
69%.
Histologic and immunohistologic analysis of endomyocar-
dial biopsy specimens. Separate histologic and immunohisto-
logic analyses of the endomyocardial biopsy specimens are
shown in Table 1. Histologically, evidence for acute myocardi-
tis was present in 1 (1.2%) of 80 patients, and evidence for
borderline myocarditis in 4 (5%) of 80 patients. In 75 (94%) of
80 patients histologic examination of the endomyocardial
biopsy specimen did not demonstrate evidence for myocarditis.
All five patients with histologically diagnosed acute or border-
line myocarditis had elevated serum levels of cTnT (Table 1).
However, elevated cTnT levels were also found in 23 (31%) of
the 75 patients, in whom histologic analysis of the biopsy
specimen was negative for myocarditis. All cTnT2 patients
had normal findings on histologic analysis of the biopsy
specimens. The sensitivity of the cTnT assay for the histologic
detection of myocarditis was 100%, the specificity 69%, the
positive predictive value 18%, the negative predictive value
100% and the effectiveness 71%.
Immunohistologic analysis of the endomyocardial biopsy
specimen showed lymphocytic myocarditis in 49 patients
(61%) and revealed no evidence for myocarditis in 31 patients
(39%) (Table 1). All patients in whom histologic study showed
evidence for acute or borderline myocarditis were also consid-
ered to have lymphocytic myocarditis by immunohistologic
analysis. Among the 28 cTnT1 patients, immunohistologic
analysis of the endomyocardial biopsy specimens showed lym-
phocytic myocarditis in 26 patients (93%) and no myocarditis
in 2 (7%). Among the 52 CTnT2 patients, immunohistologic
evidence of lymphocytic myocarditis was found in 44% (23
patients) whereas 56% (29 patients) had no evidence for
myocarditis (Table 1). The sensitivity of the cTnT assay for the
immunohistologic detection of myocarditis was 53%, the spec-
ificity 94%, the positive predictive value 93%, the negative
predictive value 56% and the effectiveness 69%.
Clinical data of patients with myocarditis. The clinical
data and the results of diagnostic procedures of the patients
with myocarditis in the cTnT1 and cTnT2 groups are given in
Table 2. The number of patients with recent onset of symptoms
(,1 month) was greater in cTnT1 than in cTnT2 in patients
(p , 0.030). The frequency of the various clinical symptoms
was equal in both groups. CK levels were elevated in four
cTnT1 patients (maximal level 682 U/liter); CK-MB levels
were elevated in one cTnT1 patient (68 U/liter). In cTnT2
patients, CK and CK-MB were always within the normal range
(p 5 0.112 and 1.000, respectively). These levels exclude
extensive skeletal muscle injury in the study patients. Impaired
renal function (creatinine .1.2 mg/dl) was found in five
cTnT1 patients and four cTnT2 patients (p , 0.763). CTnT1
and cTnT2 patients did not differ in the frequency of atrial
fibrillation, premature supraventricular beats, premature ven-
tricular beats, bundle branch block or ST segment alterations,
as analyzed by electrocardiography and Holter electrocardiog-
raphy. Echocardiography disclosed disturbed left ventricular
function in ;50% of patients in both groups; pericardial
effusion was present more often in cTnT1 patients (p ,
0.024). Hemodynamic variables at rest during ventriculography
(ejection fraction, end-diastolic volume, end-systolic volume,
stroke volume) were not different between cTnT1 and cTnT2
patients. The number of lymphocytes detected immunohisto-
logically was not different between cTnT1 and cTnT2 pa-
tients. There was no correlation between lymphocyte density
and cTnT levels (correlation coefficient [r] 5 0.0858, p , 0.575).
Discussion
Significance of cTnT, CK and CK-MB in Patients With
Clinically Suspected Myocarditis. The present study shows
that measurement of serum levels of cTnT can often provide
evidence of ongoing myocardial cell damage in patients with
clinically suspected myocarditis when conventionally used lab-
oratory variables such as CK or CK-MB are within the normal
Figure 1. Serum levels of cTnT in 80 patients with clinically suspected
myocarditis. Solid squares 5 patients with histologically or immuno-
histologically diagnosed myocarditis; open squares 5 patients whose
endomyocardial biopsy failed to show evidence of myocarditis; hori-
zontal line 5 threshold for elevated cTnT levels.
Table 1. Histologic and Immunohistologic Findings in 80 Patients
With Clinically Suspected Myocarditis With and Without Elevated
Levels of Cardiac Troponin T
cTnT1
(n 5 28)
cTnT2
(n 5 52)
Histologic findings
Acute myocarditis (n 5 1) 1 (1.25%) 0 (0%)
Borderline myocarditis (n 5 4) 4 (6%) 0 (0%)
No myocarditis (n 5 75) 23 (29%) 52 (65%)
Immunohistologic findings
Lymphocytic myocarditis (n 5 49) 26 (32.5%) 23 (29%)
No myocarditis (n 5 31) 2 (2.5%) 29 (36%)
Data presented are number (%) of the total group of 80 patients. cTnT1 5
elevated cardiac troponin T; cTnt2 5 no elevated cardiac troponin T.
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range. Among patients with histologically or immunohistolog-
ically diagnosed myocarditis, cTnT levels were elevated in
53%, whereas CK and CK-MB levels were increased in only
8% and 2%, respectively. As the half-life of cTnT in the serum
is ;2 h (23), the elevated levels of cTnT reflect truly ongoing
myocardial cell damage rather than merely recent myocyte
injury. These results demonstrate a higher sensitivity of the
cTnT assay for the detection of myocardial cell damage than
that of other cardiac enzyme determinations (23,24).
As part of the troponin complex, Troponin T is a 37-kDa
protein (25) that is responsible for the binding of the troponin
complex to tropomyosin (26). Several isoforms of troponin T
have been described, including a specific cardiac isoform that is
normally not expressed in other tissues (6,7). CTnT is normally
hardly detectable in the serum of healthy persons (9). Elevated
serum levels of cTnT are found to be a sensitive and specific
indicator for myocardial cell damage (8). In patients with acute
myocardial infarction, measurement of cTnT levels provides
better diagnostic efficiency for the detection of myocardial cell
necrosis than that of other conventionally used cardiac enzyme
measurements (23). In unstable angina pectoris, elevated
serum levels of cTnT are a more sensitive than CK as a marker
for myocardial cell damage, and such findings may be used as
a prognostic indicator in these patients (10). Serum levels of
cTnT can be used as a sensitive and specific test for the
detection of perioperative myocardial infarction in patients
Table 2. Clinical Data of 49 Patients With Myocarditis With and Without Elevated Levels of Cardiac
Troponin T
cTnT1
(n 5 26)
cTnT2
(n 5 23)
p
Value
Age (yr) 52 6 17 (12–86) 44 6 12 (22–60) 0.065
Male/female 19/7 17/6 0.811
Symptoms
Duration ,1 mo 11 3 0.030
Duration .1 mo 15 20 0.030
Angina pectoris 11 10 0.934
Dyspnea 18 19 0.333
Palpitation or pulse irregularities 7 6 0.947
Others 0 0.096
NYHA class
I 5 1 0.194
II 10 9 0.961
III 5 7 0.363
IV 6 6 0.807
Mean 6 SD 2.46 6 1.07 2.78 6 0.90 0.265
Laboratory findings
CK .70 U/liter 4 0 0.112
CK-MB .10 U/liter 1 0 1.000
Creatinine .1.2 mg/dl 5 4 0.762
Electrocardiographic changes
Absolute arrhythmia 12 6 0.146
Premature supraventricular beats 11 6 0.234
Premature ventricular beats 19 20 0.299
Atrioventricular block 4 6 0.482
Bundle branch block 11 6 0.234
ST segment changes 15 18 0.143
Echocardiographic changes
Left ventricular dysfunction 14 19 0.132
Pericardial effusion 6 0 0.024
Left ventriculographic variables (n 5 14) (n 5 18)
Ejection fraction 55 6 22 (22–85) 49 6 19 (18–73) 0.474
Stroke volume 121 6 73 (61–312) 111 6 37 (65–198) 0.621
Stroke volume index 65 6 44 (33–199) 58 6 19 (36–94) 0.585
End-diastolic volume 238 6 127 (104–466) 251 6 113 (137–625) 0.759
End-diastolic volume index 127 6 74 (60–296) 132 6 56 (70–308) 0.820
End-systolic volume 117 6 90 (25–335) 140 6 118 (49–515) 0.550
End-systolic volume index 62 6 49 (11–184) 73 6 59 (27–253) 0.567
Immunohistologic analysis
Lymphocytes/high power field 7.4 6 10.0 5.7 6 6.8 0.497
Data presented are mean value 6 SD (range) or number of patients. CK 5 creatine kinase; CK-MB 5 MB isoform
of creatine kinase; NYHA class 5 New York Heart Association functional class; other abbreviations as in Table 1.
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undergoing coronary artery bypass surgery (27), to detect
occlusions of small side branch arteries during percutaneous
coronary angioplasty (24) and to show myocardial involvement
in patients with polymyositis/dermatomyositis (28).
cTnT and results of endomyocardial biopsy. When ele-
vated cTnT levels were detected in patients with clinically
suspected myocarditis, histologic and immunohistologic anal-
ysis of the endomyocardial biopsy specimen showed evidence
of myocarditis in 93%. Thus, elevated cTnT levels were highly
predictive for myocarditis in these patients. In two cTnT1
patients the endomyocardial biopsy did not reveal evidence for
myocarditis. Possibly because of sampling error the lympho-
cytic infiltrates may have escaped histologic and immunohisto-
logic detection in these patients (14). However, antimyosin
scintigraphy with monoclonal antibodies against the cardiac
myosin heavy chain showed that in some patients the radiop-
harmacon is not evenly distributed over the myocardium. This
finding indicates a more focal nature of the disease in these
patients (29–31). Because the endomyocardial biopsy speci-
mens in our study patients were always taken from the right
heart side of the interventricular septum, a focal myocarditic
process in other regions of the heart might have been missed in
these specimens. Nevertheless, ongoing myocardial damage in
these patients could lead to increased serum levels of cTnT.
Finally, other causes of myocyte injury, such as subendocardial
ischemia in acutely dilated cardiomyopathy or toxins, cannot
be ruled out as the source of elevated cTnT levels.
Evidence of myocarditis was also found in 48% of cTnT2
patients, indicating a lower extent of myocardial damage in
these patients. cTnT2 patients had a longer duration of
symptoms before they underwent measurement of cTnT levels
and endomyocardial biopsy. It cannot be ruled out that in the
course of the disease, autoantibodies against cTnT may have
developed that might have interfered with the ELISA method
employed to quantify circulating cTnT. In contrast, it is
possible that cTnT1 patients had a more active inflammatory
process than cTnT2 patients, and that this greater activity led
to increased myocardial damage; however, the extent of lym-
phocytic infiltrates was not different between cTnT1 and
cTnT2 patients. Another possible explanation is that the
difference in cTnT levels may be due to different pathogenetic
mechanisms of the disease in patients with myocarditis. With
the use of in-situ hybridization or the polymerase chain
reaction, viral ribonucleic acid (RNA) has been detected in the
myocardium of some patients with myocarditis (32,33). In
these patients the viral infection is discussed as the pathoge-
netic mechanism of their myocardial inflammation. Other
studies (34–38) detected autoantibodies against various car-
diac structures in patients with myocarditis.
Histologic and immunohistologic analysis of endomyocar-
dial biopsy specimens. In the present study, histologic exam-
ination alone of the biopsy specimen revealed acute or bor-
derline myocarditis in 6.3% of patients with clinically
suspected myocarditis. In the Myocarditis Treatment Trial
(39), acute myocarditis was diagnosed histologically in 10% of
patients with clinically suspected myocarditis. However, histo-
logic analysis of the biopsy specimen was negative in 21 of 26
cTnT1 patients, indicating ongoing myocyte damage. These
observations indicate that histologic analysis of the biopsy
specimen according to the Dallas criteria (1) may be a rather
insensitive diagnostic procedure for the detection of myocar-
ditis.
The Dallas classification for the diagnosis of acute myocar-
ditis was initially established for various reasons by a group of
outstanding pathologists. The goals were 1) to produce a
morphologic definition of myocarditis, 2) to develop histologic
criteria for the diagnosis of myocarditis, 3) to establish a simple
reproducible working classification, 4) to outline the problems
and pitfalls of establishing the diagnosis of myocarditis, 5) to
assess the applicability and reproducibility of the classification
system itself, and 6) to make this information available to other
pathologists and clinicians (1,2). However, as these patholo-
gists have emphasized, the Dallas criteria were not meant to
establish a definite diagnosis of myocarditis and should not be
misunderstood and misinterpreted as a “conditio sine qua
non” of this diagnosis (2). Therefore, the present study used
the Dallas criteria (13) and additionally immunohistologic
techniques for the detection of lymphocytic infiltrates (11,15–
18) and an increased expression of MHC I and II antigens.
With these techniques, the diagnostic accuracy could be in-
creased (18) and the interobserver variability minimized (11).
Immunohistologic analysis revealed lymphocytic infiltrates and
increased expression of MHC I and II antigens in 93% of
cTnT1 patients with clinically suspected myocarditis. This
finding indicates that immunohistologic analysis may be a
better diagnostic tool than histologic examination alone for the
detection of myocarditis associated with myocardial cell dam-
age. We believe that the immunohistologic detection of lym-
phocytes in the myocardium together with increased expres-
sion of MHC I and II antigens as a marker for an activated
immunologic process allows the classification of these patients
as having lymphocytic myocarditis even in the absence of
histologically detectable myocyte necrosis.
The present results show that measurement of serum levels
of cTnT can provide evidence of myocardial cell damage in
patients with clinically suspected myocarditis more effectively
than can conventionally used cardiac enzyme determinations.
Myocardial cell damage may be present even in the absence of
histologic evidence of myocarditis. In these patients, additional
immunohistologic analysis of the endomyocardial biopsy spec-
imen often reveals lymphocytic infiltrates and an increased
expression of human leukocyte antigens (HLA) antigens indi-
cating myocardial inflammation. In patients with clinically
suspected myocarditis, elevated cTnT levels are highly predic-
tive for myocarditis.
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